Javascript must be enabled to continue!
Minimalno invazivna hirurgija HCC-a
View through CrossRef
Hirurško lečenje predstavlja glavni vid potencijalno kurativnog lečenja bolesnika sa hepatocelularnim karcinomom. Bolesnici sa solitarnim tumorom i cirozom jetre Child-Pugh A stadijuma smatraju se idealnim kandidatima za resekciju jetre. Kod bolesnika sa portnom hipertenzijom potrebna je pažljiva evaluacija stanja funkcije jetre a eventualnu resekciju jetre treba primeniti kod bolesnika u kompenzovanom stanju sa adekvatnim rezidualnim volumenom jetre. Primena minimalno invazivne hirurgije kod ovih bolesnika ima više prednosti uključujući smanjeno intraoperativno krvarenje, manje postoperativnih komplikacija, kraću hospitalizaciju i brži oporavak bolesnika. Tehnički izazovi se odnose na situacije kada se tumor nalazi na velikim krvnim sudovima jetre i kada je potrebno primeniti poštedne resekcije jetre. Minimalno invazivna hirurgija jetre zahteva posebnu opremu i energetske uređaje za kontrolu hemostaze tokom transekcije parenhima jetre.
University of Belgrade, Faculty of Medicine, Belgrade
Title: Minimalno invazivna hirurgija HCC-a
Description:
Hirurško lečenje predstavlja glavni vid potencijalno kurativnog lečenja bolesnika sa hepatocelularnim karcinomom.
Bolesnici sa solitarnim tumorom i cirozom jetre Child-Pugh A stadijuma smatraju se idealnim kandidatima za resekciju jetre.
Kod bolesnika sa portnom hipertenzijom potrebna je pažljiva evaluacija stanja funkcije jetre a eventualnu resekciju jetre treba primeniti kod bolesnika u kompenzovanom stanju sa adekvatnim rezidualnim volumenom jetre.
Primena minimalno invazivne hirurgije kod ovih bolesnika ima više prednosti uključujući smanjeno intraoperativno krvarenje, manje postoperativnih komplikacija, kraću hospitalizaciju i brži oporavak bolesnika.
Tehnički izazovi se odnose na situacije kada se tumor nalazi na velikim krvnim sudovima jetre i kada je potrebno primeniti poštedne resekcije jetre.
Minimalno invazivna hirurgija jetre zahteva posebnu opremu i energetske uređaje za kontrolu hemostaze tokom transekcije parenhima jetre.
Related Results
Association of Genetic Polymorphisms with Clinical Characteristics and Survival of Hepatocellular Carcinoma Patients with or without Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Association of Genetic Polymorphisms with Clinical Characteristics and Survival of Hepatocellular Carcinoma Patients with or without Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
The influence of single-nucleotide polymorphisms (SNPs) on hepatocellular carcinoma (HCC) in terms of etiological factors remains to be explored. This study evaluated the distribut...
Projected outcomes of 6‐month delay in exception points versus an equivalent Model for End‐Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates
Projected outcomes of 6‐month delay in exception points versus an equivalent Model for End‐Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates
The United Network for Organ Sharing (UNOS) recently implemented a 6‐month delay before granting exception points to liver transplantation candidates with hepatocellular carcinoma ...
Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures
Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures
AbstractBackground & AimsLymphocyte‐rich hepatocellular carcinoma (LR‐HCC) is largely unknown and a rare subtype of HCC with immune‐rich stroma. Tertiary lymphoid structures (T...
Steatohepatitic hepatocellular carcinoma: morphological diagnostic criteria and clinicopathological characteristics
Steatohepatitic hepatocellular carcinoma: morphological diagnostic criteria and clinicopathological characteristics
Abstract
According to the WHO, steatohepatitic hepatocellular carcinoma (SH-HCC) is a distinct HCC subtype. Its prevalence and prognosis vary depending on the study, probab...
Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma
Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma
Abstract
Altered gut microbiota has been connected to hepatocellular carcinoma (HCC) occurrence and advancement. This study was conducted to identify a gut microbiota s...
Evaluation of AFP, AFP-L3%, and DCP in the diagnosis and after surgery prognosis of HCC
Evaluation of AFP, AFP-L3%, and DCP in the diagnosis and after surgery prognosis of HCC
Abstract
Background
To investigate the prognostic value of alpha-fetoprotein (AFP), ratio (AFP-L3%), and Des-γ-carboxyprothrombin (DCP) in the diagnosis and surgical resec...
Outcomes after curative treatment for cryptogenic cirrhosis‐associated hepatocellular carcinoma satisfying the Milan criteria
Outcomes after curative treatment for cryptogenic cirrhosis‐associated hepatocellular carcinoma satisfying the Milan criteria
AbstractBackground and Aim: The prognosis of cryptogenic cirrhosis‐associated hepatocellular carcinoma (CC‐HCC) was reported to be poor because many of them were discovered at the...
Abstract B20: Geospatial analysis of hepatocellular carcinoma and its risk factors in Texas (1995-2010)
Abstract B20: Geospatial analysis of hepatocellular carcinoma and its risk factors in Texas (1995-2010)
Abstract
Introduction: Between 1995 and 2010 there have been 1.4 million incident cancer cases in Texas. While Hepatocellular Carcinoma (HCC) accounted for a small p...

